Dyne Therapeutics (DYN) Short Interest Ratio & Short Volume → “Dollar Will Be Worth NOTHING” -Musk (From Crypto 101 Media) (Ad) Free DYN Stock Alerts $28.75 -0.63 (-2.14%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Dyne Therapeutics Short Interest DataCurrent Short Volume9,630,000 sharesPrevious Short Volume9,020,000 sharesChange Vs. Previous Month+6.76%Dollar Volume Sold Short$243.74 millionShort Interest Ratio / Days to Cover7.8Last Record DateApril 30, 2024Outstanding Shares87,380,000 sharesFloat Size50,930,000 sharesShort Percent of Float18.91%Today's Trading Volume1,120,645 sharesAverage Trading Volume1,776,464 sharesToday's Volume Vs. Average63% Short Selling Dyne Therapeutics ? Sign up to receive the latest short interest report for Dyne Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatDYN Short Interest Over TimeDYN Days to Cover Over TimeDYN Percentage of Float Shorted Over Time Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report Dyne Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20249,630,000 shares $243.74 million +6.8%18.9%7.8 $25.31 4/15/20249,020,000 shares $229.47 million +11.6%N/A6.5 $25.44 3/31/20248,080,000 shares $229.39 million +18.5%16.2%4.7 $28.39 3/15/20246,820,000 shares $190.89 million +3.2%13.7%3.2 $27.99 2/29/20246,610,000 shares $177.81 million -8.8%16.6%3.3 $26.90 2/15/20247,250,000 shares $171.10 million -15.2%19.1%4 $23.60 Get the Latest News and Ratings for DYN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dyne Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20248,550,000 shares $182.97 million +7.3%28.8%4.9 $21.40 1/15/20247,970,000 shares $133.02 million -18.5%26.8%5.1 $16.69 6/30/20235,480,000 shares $61.65 million +12.5%17.0%10.2 $11.25 6/15/20234,870,000 shares $58.93 million -1.4%15.1%9.4 $12.10 5/31/20234,940,000 shares $64.37 million -1.0%15.8%12.1 $13.03 5/15/20234,990,000 shares $68.31 million +2.3%16.0%12.6 $13.69 4/30/20234,880,000 shares $50.56 million No Change15.3%13 $10.36 4/15/20234,880,000 shares $44.41 million +14.0%15.3%15.3 $9.10 3/31/20234,280,000 shares $49.31 million +5.2%13.5%12.5 $11.52 3/15/20234,070,000 shares $51.40 million +8.0%13.6%13.6 $12.63 2/28/20233,770,000 shares $48.56 million +1.9%12.7%11.4 $12.88 2/15/20233,700,000 shares $50.62 million +4.2%13.4%11.7 $13.68 1/31/20233,550,000 shares $51.83 million +25.0%13.0%11.7 $14.60 1/15/20232,840,000 shares $36.81 million +15.9%10.4%9.5 $12.96 12/30/20222,450,000 shares $28.40 million -11.2%8.9%8.7 $11.59 12/15/20222,760,000 shares $37.51 million +2.2%9.7%9 $13.59 11/30/20222,700,000 shares $31.59 million -5.3%9.5%11.1 $11.70 11/15/20222,850,000 shares $28.47 million +2.5%10.1%11.1 $9.99 10/31/20222,780,000 shares $31.69 million +23.6%9.7%10.3 $11.40 10/15/20222,250,000 shares $29.68 million +27.8%7.9%8.3 $13.19 9/30/20221,760,000 shares $22.35 million +38.6%6.2%6.7 $12.70 9/15/20221,270,000 shares $17.78 million +5.8%4.6%5.2 $14.00 8/31/20221,200,000 shares $11.76 million +17.7%4.4%5.1 $9.80 8/15/20221,020,000 shares $12.23 million +16.4%3.7%4.8 $11.99 7/31/2022876,500 shares $9.19 million -14.9%3.3%4.7 $10.49 7/15/20221,030,000 shares $10.56 million -73.0%3.8%5.8 $10.25 6/30/20223,820,000 shares $26.24 million +1.1%14.2%22.9 $6.87 6/15/20223,780,000 shares $20.87 million +139.2%14.0%23.2 $5.52 5/31/20221,580,000 shares $7.60 million -3.1%5.9%10.1 $4.81 5/15/20221,630,000 shares $9.10 million -2.4%6.1%10.4 $5.58 4/30/20221,670,000 shares $13.33 million +1.2%6.2%10.3 $7.98 4/15/20221,650,000 shares $15.81 million +1.2%6.1%8.6 $9.58 3/31/20221,630,000 shares $15.71 million -3.0%6.2%6.8 $9.64 3/15/20221,680,000 shares $14.50 million -28.8%6.4%7.1 $8.63The #1 Investment of the Decade… (Ad)Sam Altman, the CEO of OpenAI, has invested $375 million into a breakthrough technology, that legendary financial analyst Porter Stansberry believes… …could be the number-one investment of the decade.To get all the details of this controversial tech – click here now. DYN Short Interest - Frequently Asked Questions What is Dyne Therapeutics' current short interest? Short interest is the volume of Dyne Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 9,630,000 shares of DYN short. 18.91% of Dyne Therapeutics' shares are currently sold short. Learn More on Dyne Therapeutics' current short interest. What is a good short interest ratio for Dyne Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DYN shares currently have a short interest ratio of 8.0. Learn More on Dyne Therapeutics's short interest ratio. What is a good short interest percentage for Dyne Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.91% of Dyne Therapeutics' floating shares are currently sold short. Is Dyne Therapeutics' short interest increasing or decreasing? Dyne Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 9,630,000 shares, an increase of 6.8% from the previous total of 9,020,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Dyne Therapeutics' float size? Dyne Therapeutics currently has issued a total of 87,380,000 shares. Some of Dyne Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Dyne Therapeutics currently has a public float of 50,930,000 shares. How does Dyne Therapeutics' short interest compare to its competitors? 18.91% of Dyne Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Dyne Therapeutics: PTC Therapeutics, Inc. (12.95%), Bausch Health Companies Inc. (5.73%), MoonLake Immunotherapeutics (14.00%), ACADIA Pharmaceuticals Inc. (7.28%), Merus (5.76%), Janux Therapeutics, Inc. (9.55%), Indivior PLC (0.14%), Rhythm Pharmaceuticals, Inc. (17.37%), TG Therapeutics, Inc. (27.08%), MorphoSys AG (0.83%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Dyne Therapeutics stock? Short selling DYN is an investing strategy that aims to generate trading profit from Dyne Therapeutics as its price is falling. DYN shares are trading down $0.63 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Dyne Therapeutics? A short squeeze for Dyne Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DYN, which in turn drives the price of the stock up even further. How often is Dyne Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DYN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: PTC Therapeutics Short Squeeze Bausch Health Companies Short Squeeze MoonLake Immunotherapeutics Short Squeeze ACADIA Pharmaceuticals Short Squeeze Merus Short Squeeze Janux Therapeutics Short Squeeze Indivior Short Squeeze Rhythm Pharmaceuticals Short Squeeze TG Therapeutics Short Squeeze MorphoSys Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DYN) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe 1,000X Crypto PlaybookTrue Market InsidersCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMost important medical advance in 100 yearsThe Oxford ClubBill Clinton Backing Biden Replacement???The Freeport SocietyCharles Payne Demystifies OptionsUnstoppable ProsperityWhy Is Gold On a MASSIVE rally? Huge Alerts